BSX - Boston Scientific Corporation
After hours:
| Previous close | 51.07 |
| Open | 51.13 |
| Bid | 51.30 x 1200 |
| Ask | 52.75 x 1200 |
| Day's range | 50.91 - 51.54 |
| 52-week range | 34.98 - 54.17 |
| Volume | |
| Avg. volume | 9,403,941 |
| Market cap | 73.725B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 86.92 |
| EPS (TTM) | 0.59 |
| Earnings date | 25 Jul 2023 - 31 Jul 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 54.16 |
ZacksCatalent (CTLT) Launches Expanded OneBio Suite to Aid Customers
Catalent's (CTLT) expansion of its OneBio Suite across multiple biologic therapies is expected to aid customers in leveraging its end-to-end capabilities in these areas.
- Zacks
Inari Medical (NARI) Launches New Catheters to Address VTE
Inari Medical's (NARI) latest launches are expected to serve a wider patient pool by improving treatment options.
Zacks3 Reasons to Retain Intuitive Surgical (ISRG) Stock for Now
Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.
ZacksMasimo's (MASI) New FDA Approval to Boost Patient Monitoring
Masimo's (MASI) Radius VSM is expected to equip any hospital bed with comprehensive monitoring and offer more personalized care without additional bedside equipment.
ZacksHealthEquity (HQY) Surpasses Q1 Earnings Estimates, FY24 View Up
HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the first quarter of fiscal 2024.
- Zacks
Here's Why You Should Hold Integer Holdings (ITGR) Stock for Now
Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.
ZacksHere's Why You Should Retain AMN Healthcare (AMN) Stock for Now
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
Simply Wall St.Boston Scientific (NYSE:BSX) shareholders have earned a 8.6% CAGR over the last five years
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But the truth is...
- Zacks
Here's Why You Should Retain PacBio (PACB) Stock for Now
PacBio's (PACB) product development activities raise optimism about the stock.
- Zacks
Veeva Systems (VEEV) Beats on Q1 Earnings, Ups FY24 Outlook
Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both segments.
ZacksHere's Why You Should Retain DaVita (DVA) Stock for Now
Investors remain optimistic about DaVita (DVA) due to the strength of its DaVita Kidney Care.
- Simply Wall St.
Investors Could Be Concerned With Boston Scientific's (NYSE:BSX) Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...
ZacksVeeva Systems (VEEV) Extends Tie-Up With Lotus Clinical
Veeva Systems (VEEV) expands its partnership with Lotus Clinical to accelerate clinical trials.
- Zacks
Boston Scientific (BSX) Rises 26.4%: Will the Rally Continue?
Boston Scientific (BSX) gains from strong improvement in organic sales, indicating a solid rebound in the legacy business.
ZacksIs Augmedix (AUGX) Outperforming Other Medical Stocks This Year?
Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
- Zacks
Catalent (CTLT) Expands Its Facility Capabilities in Shiga
Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Supply Services network.
- Simply Wall St.
Can Boston Scientific Corporation (NYSE:BSX) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Boston Scientific's (NYSE:BSX) stock is up by 9.1% over the past three months. However, the company's financials look a...
ZacksWhy Is Boston Scientific (BSX) Down 0.9% Since Last Earnings Report?
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Veeva Systems (VEEV) Offerings Adopted by Minaris Regenerative
Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.
ZacksMedtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
- Zacks
Masimo's (MASI) Platform Expansion to Boost Patient Monitoring
Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.
ZacksBoston Scientific (BSX) Gains From Acquisitions, New Launches
Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.
ZacksAccuray (ARAY) Hits 52-Week High: What's Aiding the Stock?
Investors are optimistic about Accuray's (ARAY) solid product portfolio.
- Zacks
Veeva Systems' (VEEV) New Tie-Up to Improve Clinical Trials
Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.
- Simply Wall St.
Boston Scientific Corporation's (NYSE:BSX) Intrinsic Value Is Potentially 20% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Boston Scientific fair value estimate is US$41.38 Current...
